Via Transportation, Inc. delivers digital platforms for public mobility across the United States, Germany, and other international markets. Central to its offerings is "TransitTech," a specialized public mobility platform designed to empower partners in establishing comprehensive, integrated transit systems. This involves expert planning and scheduling to seamlessly weave multiple transportation modes into a unified network. The company provides tailored solutions for various sectors, including flexible on-demand microtransit, paratransit, student transport, non-emergency medical journeys (NEMT), corporate and university shuttle services, and broader health-related travel. Via's extensive client roster includes cities, public transit authorities and operators, paratransit providers, educational institutions (from school districts to universities), private corporations, healthcare organizations, and ultimately serves both passengers and drivers. Established in 2012, the firm maintains its headquarters in New York, New York.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Cymabay Therapeutics stocks are traded under the ticker C0I.MU.
When is the next Cymabay Therapeutics earnings date?▼
Cymabay Therapeutics is going to release the next earnings report on September 02, 2026.
What were Cymabay Therapeutics earnings last quarter?▼
C0I.MU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.05 EUR resulting in a +16.12% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Cymabay Therapeutics have?▼
As of July 09, 2026, the company has 973 employees.
In which sector is Cymabay Therapeutics located?▼
Cymabay Therapeutics operates in the Manufacturing sector.
When did Cymabay Therapeutics complete a stock split?▼
Cymabay Therapeutics has not had any recent stock splits.
Where is Cymabay Therapeutics headquartered?▼
Cymabay Therapeutics is headquartered in New York, United States.